Arkuda Therapeutics
生物技术研究
Watertown，Massachusetts 1,830 位关注者
Discovering therapies to change the trajectory of neurodegenerative disease
关于我们
Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.
- 网站
-
https://www.arkudatx.com
Arkuda Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Watertown，Massachusetts
- 类型
- 私人持股
- 领域
- neurodegenerative disease、FTD-GRN、biotechnology和drugdiscovery
地点
-
主要
获取路线
200 Arsenal Yards Boulevard
Suite 220
US，Massachusetts，Watertown，02472
Arkuda Therapeutics员工
-
Pascale Witz
Chair, Board Director, Advisor, Former CEO, Investor, Author / Pharma & Biotech, Digital Health, MedTech
-
Marian Nakada, Ph.D.
Using BIG for GOOD. Making strategic investments for Johnson & Johnson Innovation - JJDC
-
Bruce Booth
Partner at Atlas Venture
-
Chris O'Donnell
Partner, Pfizer Ventures & Vice President, Partnering Innovations